Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparing different robots available in the European market for the preparation of injectable chemotherapy and recommendations to users.
Cerutti A, Ledoux T, Vantard N, Cerfon MA, Kimbidima R, Larbre V, Herledan C, Lattard C, Baudouin A, Caffin AG, Schwiertz V, Ranchon F, Rioufol C. Cerutti A, et al. Among authors: rioufol c. J Oncol Pharm Pract. 2023 Oct;29(7):1599-1612. doi: 10.1177/10781552221143786. Epub 2022 Dec 14. J Oncol Pharm Pract. 2023. PMID: 36999226 Review.
SMABcare study: subcutaneous monoclonal antibody in cancer care: cost-consequence analysis of subcutaneous rituximab in patients with follicular lymphoma.
Fargier E, Ranchon F, Huot L, Guerre P, Safar V, Dony A, Hequet N, Bachy E, Savouroux S, Fronteau C, Tomaré P, Tournamille JF, Schwiertz V, Vantard N, Le Gouill S, Gyan E, Salles G, Rioufol C. Fargier E, et al. Among authors: rioufol c. Ann Hematol. 2018 Jan;97(1):123-131. doi: 10.1007/s00277-017-3147-y. Epub 2017 Oct 10. Ann Hematol. 2018. PMID: 28993857
SIMulation of Medication Error induced by Clinical Trial drug labeling: the SIMME-CT study.
Dollinger C, Schwiertz V, Sarfati L, Gourc-Berthod C, Guédat MG, Alloux C, Vantard N, Gauthier N, He S, Kiouris E, Caffin AG, Bernard D, Ranchon F, Rioufol C. Dollinger C, et al. Among authors: rioufol c. Int J Qual Health Care. 2016 Jun;28(3):311-5. doi: 10.1093/intqhc/mzw025. Epub 2016 Mar 13. Int J Qual Health Care. 2016. PMID: 26976831
Adherence to oral anticancer chemotherapy: What influences patients' over or non-adherence? Analysis of the OCTO study through quantitative-qualitative methods.
Bourmaud A, Henin E, Tinquaut F, Regnier V, Hamant C, Colomban O, You B, Ranchon F, Guitton J, Girard P, Freyer G, Tod M, Rioufol C, Trillet-Lenoir V, Chauvin F. Bourmaud A, et al. Among authors: rioufol c. BMC Res Notes. 2015 Jul 4;8:291. doi: 10.1186/s13104-015-1231-8. BMC Res Notes. 2015. PMID: 26142140 Free PMC article.
Over-adherence to capecitabine: a potential safety issue in breast and colorectal cancer patients.
Le Saux O, Bourmaud A, Rioufol C, Colomban O, Guitton J, Schwiertz V, Regnier V, You B, Ranchon F, Maraval-Gaget R, Girard P, Chauvin F, Freyer G, Tod M, Henin E, Trillet-Lenoir V. Le Saux O, et al. Among authors: rioufol c. Cancer Chemother Pharmacol. 2018 Aug;82(2):319-327. doi: 10.1007/s00280-018-3612-x. Epub 2018 Jun 15. Cancer Chemother Pharmacol. 2018. PMID: 29948022
93 results